654 related articles for article (PubMed ID: 29110146)
1. Atherosclerosis, Periodontal Disease, and Treatment with Resolvins.
Hamilton JA; Hasturk H; Kantarci A; Serhan CN; Van Dyke T
Curr Atheroscler Rep; 2017 Nov; 19(12):57. PubMed ID: 29110146
[TBL] [Abstract][Full Text] [Related]
2. Resolvin E1 (RvE1) Attenuates Atherosclerotic Plaque Formation in Diet and Inflammation-Induced Atherogenesis.
Hasturk H; Abdallah R; Kantarci A; Nguyen D; Giordano N; Hamilton J; Van Dyke TE
Arterioscler Thromb Vasc Biol; 2015 May; 35(5):1123-33. PubMed ID: 25792445
[TBL] [Abstract][Full Text] [Related]
3. Resolvins as proresolving inflammatory mediators in cardiovascular disease.
Capó X; Martorell M; Busquets-Cortés C; Tejada S; Tur JA; Pons A; Sureda A
Eur J Med Chem; 2018 Jun; 153():123-130. PubMed ID: 28732558
[TBL] [Abstract][Full Text] [Related]
4. The management of inflammation in periodontal disease.
Van Dyke TE
J Periodontol; 2008 Aug; 79(8 Suppl):1601-8. PubMed ID: 18673016
[TBL] [Abstract][Full Text] [Related]
5. Plaque Rupture and Thrombosis: the Value of the Atherosclerotic Rabbit Model in Defining the Mechanism.
Abela OG; Ahsan CH; Alreefi F; Salehi N; Baig I; Janoudi A; Abela GS
Curr Atheroscler Rep; 2016 Jun; 18(6):29. PubMed ID: 27091328
[TBL] [Abstract][Full Text] [Related]
6. Boosting Inflammation Resolution in Atherosclerosis: The Next Frontier for Therapy.
Fredman G; Tabas I
Am J Pathol; 2017 Jun; 187(6):1211-1221. PubMed ID: 28527709
[TBL] [Abstract][Full Text] [Related]
7. RvE1 protects from local inflammation and osteoclast- mediated bone destruction in periodontitis.
Hasturk H; Kantarci A; Ohira T; Arita M; Ebrahimi N; Chiang N; Petasis NA; Levy BD; Serhan CN; Van Dyke TE
FASEB J; 2006 Feb; 20(2):401-3. PubMed ID: 16373400
[TBL] [Abstract][Full Text] [Related]
8. Paradigm shift in the pharmacological management of periodontal diseases.
Hasturk H; Kantarci A; Van Dyke TE
Front Oral Biol; 2012; 15():160-76. PubMed ID: 22142963
[TBL] [Abstract][Full Text] [Related]
9. Stabilisation of atherosclerotic plaques. Position paper of the European Society of Cardiology (ESC) Working Group on atherosclerosis and vascular biology.
Ylä-Herttuala S; Bentzon JF; Daemen M; Falk E; Garcia-Garcia HM; Herrmann J; Hoefer I; Jukema JW; Krams R; Kwak BR; Marx N; Naruszewicz M; Newby A; Pasterkamp G; Serruys PW; Waltenberger J; Weber C; Tokgözoglu L
Thromb Haemost; 2011 Jul; 106(1):1-19. PubMed ID: 21670845
[TBL] [Abstract][Full Text] [Related]
10. Non-antibacterial tetracyclines modulate mediators of periodontitis and atherosclerotic cardiovascular disease: a mechanistic link between local and systemic inflammation.
Gu Y; Lee HM; Sorsa T; Salminen A; Ryan ME; Slepian MJ; Golub LM
Pharmacol Res; 2011 Dec; 64(6):573-9. PubMed ID: 21771657
[TBL] [Abstract][Full Text] [Related]
11. The Beneficial Therapy with Colchicine for Atherosclerosis via Anti-inflammation and Decrease in Hypertriglyceridemia.
Spartalis M; Spartalis E; Tzatzaki E; Tsilimigras DI; Moris D; Kontogiannis C; Kaminiotis VV; Paschou SA; Chatzidou S; Siasos G; Voudris V; Iliopoulos DC
Cardiovasc Hematol Agents Med Chem; 2018; 16(2):74-80. PubMed ID: 30526472
[TBL] [Abstract][Full Text] [Related]
12. Development of anti-atherosclerosis therapy based on the inflammatory and proliferative aspects of the disease.
Maranhão RC; Leite AC
Curr Pharm Des; 2015; 21(9):1196-204. PubMed ID: 25312729
[TBL] [Abstract][Full Text] [Related]
13. Lipoxins and resolvins in inflammatory bowel disease.
Weylandt KH; Kang JX; Wiedenmann B; Baumgart DC
Inflamm Bowel Dis; 2007 Jun; 13(6):797-9. PubMed ID: 17262807
[TBL] [Abstract][Full Text] [Related]
14. Biologic plausibility, cellular effects, and molecular mechanisms of eicosapentaenoic acid (EPA) in atherosclerosis.
Borow KM; Nelson JR; Mason RP
Atherosclerosis; 2015 Sep; 242(1):357-66. PubMed ID: 26253795
[TBL] [Abstract][Full Text] [Related]
15. Thrombosis formation on atherosclerotic lesions and plaque rupture.
Badimon L; Vilahur G
J Intern Med; 2014 Dec; 276(6):618-32. PubMed ID: 25156650
[TBL] [Abstract][Full Text] [Related]
16. [Basic research of fibrosis on atherosclerotic plaque stability and related drug application].
Yin J; Li Q; Zhao Z; Yang Q; Li YJ; Chen Y; Wang YJ; Weng XG; Cai WY; Zhu XX
Zhongguo Zhong Yao Za Zhi; 2019 Jan; 44(2):235-241. PubMed ID: 30989939
[TBL] [Abstract][Full Text] [Related]
17. Lipid and smooth muscle architectural pathology in the rabbit atherosclerotic vessel wall using Q-space cardiovascular magnetic resonance.
Taylor EN; Huang N; Lin S; Mortazavi F; Wedeen VJ; Siamwala JH; Gilbert RJ; Hamilton JA
J Cardiovasc Magn Reson; 2022 Dec; 24(1):74. PubMed ID: 36544161
[TBL] [Abstract][Full Text] [Related]
18. "Pro-resolution" and anti-inflammation, a role of RvE1 in anti-atherosclerosis and plaque stabilization.
Wu C; Sun A; Zou Y; Ge J
Med Hypotheses; 2008 Aug; 71(2):252-5. PubMed ID: 18495368
[TBL] [Abstract][Full Text] [Related]
19. Control of inflammation and periodontitis.
Van Dyke TE
Periodontol 2000; 2007; 45():158-66. PubMed ID: 17850455
[No Abstract] [Full Text] [Related]
20. Resolvin E1 regulates inflammation at the cellular and tissue level and restores tissue homeostasis in vivo.
Hasturk H; Kantarci A; Goguet-Surmenian E; Blackwood A; Andry C; Serhan CN; Van Dyke TE
J Immunol; 2007 Nov; 179(10):7021-9. PubMed ID: 17982093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
